1334 OBT698: a promising novel agonistic antibody for immuno-oncology and its potential as a cancer therapy for solid tumors
Main Authors: | Chantia Carroll, Arnima Bisht, Chander Peddaboina, Harald Haeske, Christian Rohlff |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Similar Items
-
Concepts for agonistic targeting of CD40 in immuno-oncology
by: David M. Richards, et al.
Published: (2020-02-01) -
The promise of Immuno-oncology: implications for defining the value of cancer treatment
by: Howard L. Kaufman, et al.
Published: (2019-05-01) -
Resenha de: A History of Japan to 1334
by: Pedro Moacyr Campos
Published: (1959-12-01) -
Influence of PVT Variation and Threshold Selection on OBT and OBIST Fault Detection in RFCMOS Amplifiers
by: Hendrik P. Nel, et al.
Published: (2023-01-01) -
H2S safety in production operations [videorecording] : 65.1334
by: Petroleum Extension Service. The University of Texas at Austin
Published: (1977)